Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

Mutations affecting segment number and polarity in Drosophila

Nüsslein‐Volhard, C., & Wieschaus, E. F. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370 · see citing works

Myofibroblasts and mechano-regulation of connective tissue remodelling

Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · see citing works

TGF-β signaling and the fibrotic response

Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319 · see citing works

The Myofibroblast

Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068 · see citing works

‘The Ideal Mesh?'

Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,791 · see citing works

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

Loeys, B., Chen, J., Neptune, E., Judge, D. P., Podowski, M., Holm, T. M., Meyers, J. L., Leitch, C. C., Katsanis, N., Sharifi, N., et al. (2005) · Nature Genetics · doi:10.1038/ng1511 · Cited by 1,786 · see citing works

Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice

Dráb, M., Verkade, P., Elger, M., Kasper, M. E., Löhn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,555 · see citing works

Scleroderma

Gabrielli, A., Avvedimento, E. V., & Krieg, T. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,388 · see citing works

Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair

Bucala, R., Spiegel, L. A., Chesney, J. A., Hogan, M. M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,307 · see citing works

Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities

Razani, B., Engelman, J. A., Wang, X., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105408200 · Cited by 1,163 · see citing works

Diversity, topographic differentiation, and positional memory in human fibroblasts

Chang, H. Y., Chi, J., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162488599 · Cited by 1,151 · see citing works

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

Phillips, R. J., Burdick, M. D., Hong, K. M., Lutz, M., Murray, L. A., Xue, Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20997 · Cited by 1,071 · see citing works

TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease

Willis, B. C., & Borok, Z. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00163.2007 · Cited by 1,044 · see citing works

EMT: When epithelial cells decide to become mesenchymal-like cells

Kalluri, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39675 · Cited by 953 · see citing works

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843 · see citing works

Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor

Razani, B., Zhang, X. L., Bitzer, M., von Gersdorff, G., Böttinger, E. P., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008340200 · Cited by 640 · see citing works

Endothelial–Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis

Hashimoto, N., Phan, S. H., Imaizumi, K., Matsuo, M., Nakashima, H., Kawabe, T., Shimokata, K., & Hasegawa, Y. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0031oc · Cited by 445 · see citing works

Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma

Yamamoto, T., Takagawa, S., Katayama, I., Yamazaki, K., Hamazaki, Y., Shinkai, H., & Nishioka, K. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00528.x · Cited by 434 · see citing works

Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury

Dulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G., & Peduto, L. (2012) · Nature Medicine · doi:10.1038/nm.2848 · Cited by 418 · see citing works

Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation

Frid, M. G., Kale, V. A., & Stenmark, K. R. (2002) · Circulation Research · doi:10.1161/01.res.0000021432.70309.28 · Cited by 418 · see citing works

Systemic and cell type-specific gene expression patterns in scleroderma skin

Whitfield, M. L., Finlay, D. R., Murray, J. I., Troyanskaya, O. G., Chi, J., Pergamenschikov, A., McCalmont, T. H., Brown, P. O., Botstein, D., & Connolly, M. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635114100 · Cited by 408 · see citing works

Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis

Andersson‐Sjöland, A., de Alba, C. G., Nihlberg, K., Becerril, C., Ramı́rez, R., Pardo, A., Westergren‐Thorsson, G., & Selman, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.012 · Cited by 360 · see citing works

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

Riemekasten, G., Philippe, A., Näther, M., Slowinski, T., Müller, D. N., Heidecke, H., Matucci‐Cerinic, M., Czirják, L., Lukitsch, I., Becker, M. O., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135772 · Cited by 308 · see citing works

A stromal address code defined by fibroblasts

Parsonage, G., Filer, A. D., Haworth, O., Nash, G. B., Rainger, G. E., Salmon, M., & Buckley, C. D. (2005) · Trends in Immunology · doi:10.1016/j.it.2004.11.014 · Cited by 297 · see citing works

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Rajkumar, V. S., Howell, K., Csiszar, K., Denton, C. P., Black, C. M., & Abraham, D. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1790 · Cited by 242 · see citing works

Wnt/β‐catenin signaling is hyperactivated in systemic sclerosis and induces Smad‐dependent fibrotic responses in mesenchymal cells

Wei, J., Fang, F., Lam, A. P., Sargent, J. L., Hamburg, E., Hinchcliff, M. E., Gottardi, C. J., Atit, R., Whitfield, M. L., & Varga, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34424 · Cited by 226 · see citing works

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

Saito, E., Fujimoto, M., Hasegawa, M., Komura, K., Hamaguchi, Y., Kaburagi, Y., Nagaoka, T., Takehara, K., Tedder, T. F., & Sato, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15078 · Cited by 225 · see citing works

Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?

Wei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30312 · Cited by 214 · see citing works

Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1

Eferl, R., Hasselblatt, P., Rath, M., Popper, H., Zenz, R., Komnenovic, V., Idarraga, M. H., Kenner, L., & Wagner, E. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801414105 · Cited by 207 · see citing works

Postnatal induction of transforming growth factor β signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma

Sonnylal, S., Denton, C. P., Zheng, B., Keene, D. R., He, R., Adams, H. P., VanPelt, C. S., Geng, Y., Deng, J. M., Behringer, R. R., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22328 · Cited by 198 · see citing works

Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis

Sonnylal, S., Shiwen, X., Leoni, P., Naff, K. A., Pelt, C. S. V., Nakamura, H., Leask, A., Abraham, D., Bou–Gharios, G., & Crombrugghe, B. D. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27382 · Cited by 196 · see citing works

Mechanisms and consequences of fibrosis in systemic sclerosis

Denton, C. P., Black, C. M., & Abraham, D. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0115 · Cited by 181 · see citing works

Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis

Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomčík, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34444 · Cited by 162 · see citing works

Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways

Lee, C. G., Homer, R., Cohn, L. E., Link, H., Jung, S. S., Craft, J. E., Graham, B. S., Johnson, T. R., & Elias, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206395200 · Cited by 155 · see citing works

A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity

Sargent, J. L., Milano, A., Bhattacharyya, S., Varga, J., Connolly, M. K., Chang, H. Y., & Whitfield, M. L. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.318 · Cited by 148 · see citing works

Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice

Denton, C. P., Zheng, B., Evans, L. A., Shiwen, X., Ong, V. H., Fisher, I. B., Lazaridis, K., Abraham, D., Black, C. M., & Crombrugghe, B. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300636200 · Cited by 141 · see citing works

Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK

Chen, Y., Shiwen, X., Beek, J. V., Kennedy, L., McLeod, M. R., Renzoni, E. A., Bou–Gharios, G., Wilcox‐Adelman, S. A., Goetinck, P. F., Eastwood, M., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61252-7 · Cited by 135 · see citing works

Adenosine A 2A receptors in diffuse dermal fibrosis: Pathogenic role in human dermal fibroblasts and in a murine model of scleroderma

Chan, E. S. L., Fernandez, P., Merchant, A., Montesinos, M. C., Trzaska, S., Desai, A., Tung, C., Khoa, D. N. Y., Pillinger, M. H., Reiss, A. B., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21974 · Cited by 134 · see citing works

An Essential Role for Resident Fibroblasts in Experimental Lung Fibrosis Is Defined by Lineage-Specific Deletion of High-Affinity Type II Transforming Growth Factor β Receptor

Hoyles, R. K., Derrett‐Smith, E. C., Khan, K., Shiwen, X., Howat, S., Wells, A. U., Abraham, D., & Denton, C. P. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0279oc · Cited by 128 · see citing works

Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts

Shiwen, X., Renzoni, E. A., Kennedy, L., Howat, S., Chen, Y., Pearson, J. D., Bou–Gharios, G., Dashwood, M. R., du Bois, R. M., Black, C. M., et al. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.06.003 · Cited by 116 · see citing works

Targeting ADAM‐17/notch signaling abrogates the development of systemic sclerosis in a murine model

Kavian, N., Servettaz, A., Mongaret, C., Wang, A. A., Nicco, C., Chéreau, C., Grange, P., Vuiblet, V., Birembaut, P. L., Diébold, M.-D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27626 · Cited by 113 · see citing works

Endothelial-Mesenchymal Transition Occurs during Embryonic Pulmonary Artery Development

Arciniegas, E., Neves, C. Y., Carrillo, L. M., Zambrano, E. A., & Ramírez, R. (2005) · Endothelium · doi:10.1080/10623320500227283 · Cited by 107 · see citing works

Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide

Tourkina, E., Bonner, M., Oates, J., Hofbauer, A., Richard, M., Znoyko, S., Visconti, R. P., Zhang, J., Hatfield, C. M., Silver, R. M., et al. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-15 · Cited by 104 · see citing works

Inhibition of activator protein 1 signaling abrogates transforming growth factor β–mediated activation of fibroblasts and prevents experimental fibrosis

Avouac, J., Palumbo, K., Tomčík, M., Zerr, P., Dees, C., Horn, A., Maurer, B., Akhmetshina, A., Beyer, C., Sadowski, A., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33501 · Cited by 96 · see citing works

Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance

Cepeda, E. J., & Reveille, J. D. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000144760.37777.fa · Cited by 93 · see citing works

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls

Young‐Min, S. A., Beeton, C. A., Laughton, R., Plumpton, T. A., Bartram, S., Murphy, G., Black, C. M., & Cawston, T. E. (2001) · Annals of the Rheumatic Diseases · doi:10.1016/s0003-4967(24)43384-0 · Cited by 83 · see citing works

The effect of transforming growth factor β on rates of procollagen synthesis and degradation in vitro

McAnulty, R. J., Campa, J. S., Cambrey, A. D., & Laurent, G. J. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90066-7 · Cited by 82 · see citing works

Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis

Horn, A., Kireva, T., Palumbo‐Zerr, K., Dees, C., Tomčík, M., Cordazzo, C., Zerr, P., Akhmetshina, A., Ruat, M., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200883 · Cited by 81 · see citing works

Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets

Greenblatt, M. B., Sargent, J. L., Farina, G. A., Tsang, K., Lafyatis, R., Glimcher, L. H., Whitfield, M. L., & Aliprantis, A. O. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.024 · Cited by 81 · see citing works

New Insights into the Role of Oxidative Stress in Scleroderma Fibrosis

Gabrielli, A., Svegliati, S., Moroncini, G., & Amico, D. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010087 · Cited by 76 · see citing works

Peripheral blood fibrocytes: novel fibroblast-like cells that present antigen and mediate tissue repair

Chesney, J. A., & Bucala, R. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250520 · Cited by 67 · see citing works

Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts

Shiwen, X., Thompson, K., Khan, K., Liu, S., Murphy‐Marshman, H., Baron, M. G., Denton, C. P., Leask, A., & Abraham, D. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes234 · Cited by 65 · see citing works

The Relaxin Gene Knockout Mouse: A Model of Progressive Scleroderma

Samuel, C. S., Zhao, C., Yang, Q., Wang, H., Tian, H., Tregear, G. W., & Amento, E. P. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23880.x · Cited by 64 · see citing works

Fibroblast‐specific perturbation of transforming growth factor β signaling provides insight into potential pathogenic mechanisms of scleroderma‐associated lung fibrosis: Exaggerated response to alveolar epithelial injury in a novel mouse model

Hoyles, R. K., Khan, K., Shiwen, X., Howat, S., Lindahl, G. E., Leoni, P., du Bois, R. M., Wells, A. U., Black, C. M., Abraham, D., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23379 · Cited by 60 · see citing works

Circulating fibrocytes are increased in children and young adults with pulmonary hypertension

Yeager, M. E., Nguyen, C. M., Belchenko, D. D., Colvin, K. L., Takatsuki, S., Ivy, D. D., & Stenmark, K. R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00072311 · Cited by 56 · see citing works

Demonstration of Autoimmunity in the Tight Skin-2 Mouse: A Model for Scleroderma

Gentiletti, J., McCloskey, L. J., Artlett, C. M., Peters, J., Jiménez, S. A., & Christner, P. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2418 · Cited by 54 · see citing works

Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis

Katebi, M., Fernández, P., Chan, E. S. L., & Cronstein, B. N. (2008) · Inflammation · doi:10.1007/s10753-008-9078-y · Cited by 52 · see citing works

Gut fibrosis with altered colonic contractility in a mouse model of scleroderma

Thoua, N. M., Derrett‐Smith, E. C., Khan, K., Dooley, A., Shiwen, X., & Denton, C. P. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes191 · Cited by 43 · see citing works

Markers of joint destruction: principles, problems, and potential

Young‐Min, S. A., CAWSTON, T. E., & GRIFFITHS, I. D. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.6.545a · Cited by 37 · see citing works

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma

Derrett‐Smith, E. C., Dooley, A., Khan, K., Shiwen, X., Abraham, D., & Denton, C. P. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2986 · Cited by 31 · see citing works

The Role of Fibrocytes in Sickle Cell Lung Disease

Field, J. J., Burdick, M. D., DeBaun, M. R., Strieter, B. A., Liu, L., Mehrad, B., Rose, C. E., Linden, J., & Strieter, R. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033702 · Cited by 23 · see citing works

Getting Out of a Sticky Situation: Targeting the Myofibroblast in Scleroderma

Leask, A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010163 · Cited by 22 · see citing works

Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders

Budd, D. C., & Holmes, A. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.06.001 · Cited by 21 · see citing works

Heart involvement in patients with systemic sclerosis is mimicked by Fra-2 transgenic mice

Venalis, P., Distler, O., Lundberg, I. E., Schett, G. A., & Distler, J. H. W. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201235.10 · Cited by 1 · see citing works

Systemic sclerosis

Denton, C. P., & Khanna, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30933-9 · Cited by 2,257 · see citing works

Fibroblasts in fibrosis: novel roles and mediators

Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082 · see citing works

Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension

Good, R. B., Gilbane, A. J., Trinder, S. L., Denton, C. P., Coghlan, G., Abraham, D. J., & Holmes, A. M. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.03.019 · Cited by 349 · see citing works

The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer

Hammouda, M., Ford, A. E., Liu, Y., & Zhang, J. Y. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 289 · see citing works

Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases

Piera-Velázquez, S., Mendoza, F. A., & Jiménez, S. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040045 · Cited by 276 · see citing works

The innate immune system, toll-like receptors and dermal wound healing: A review

Portou, M. J., Baker, D., Abraham, D., & Tsui, J. C. S. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.02.007 · Cited by 233 · see citing works

MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts

Wang, D., Zhang, H., Li, M., Frid, M. G., Flockton, A. R., McKeon, B. A., Yeager, M. E., Fini, M. A., Morrell, N. W., Pullamsetti, S. S., et al. (2013) · Circulation Research · doi:10.1161/circresaha.114.301633 · Cited by 215 · see citing works

Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis

Maugeri, N., Capobianco, A., Rovere, P. Q., Ramirez, G. A., Tombetti, E., Valle, P. D., Monno, A., D’Alberti, V., Gasparri, A. M., Franchini, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3089 · Cited by 215 · see citing works

Cellular and molecular mechanisms of Hedgehog signalling

Zhang, Y., & Beachy, P. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00591-1 · Cited by 203 · see citing works

Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis

Denton, C. P., Ong, V. H., Xu, S., Chen-Harris, H., Modrusan, Z., Lafyatis, R., Khanna, D., Jahreis, A., Siegel, J., & Sornasse, T. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213031 · Cited by 166 · see citing works

Endoplasmic reticulum stress enhances fibrosis through IRE1α‐mediated degradation of miR‐150 and XBP‐1 splicing

Heindryckx, F., Binet, F., Ponticos, M., Rombouts, K., Lau, J., Kreuger, J., & Gerwins, P. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505925 · Cited by 166 · see citing works

Human Fibrotic Diseases: Current Challenges in Fibrosis Research

Rosenbloom, J., Macarak, E. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7113-8_1 · Cited by 157 · see citing works

Unraveling SSc Pathophysiology; The Myofibroblast

van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153 · see citing works

Gastrointestinal Manifestations of Systemic Sclerosis

McFarlane, I. M., Bhamra, M. S., Kreps, A., Iqbal, S., Ani, F. A., Saladini‐Aponte, C., Grant, C., Singh, S., Awwal, K., Koci, K., et al. (2018) · Rheumatology Current Research · doi:10.4172/2161-1149.1000235 · Cited by 144 · see citing works

Endothelial‐to‐mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry

Sánchez‐Duffhues, G., de Vinuesa, A. G., & ten Dijke, P. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24589 · Cited by 143 · see citing works

The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases

Wermuth, P. J., & Jiménez, S. A. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0047-4 · Cited by 138 · see citing works

Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases

Mira-Avendano, I. C., Abril, A., Burger, C. D., Dellaripa, P. F., Fischer, A., Gotway, M. B., Lee, A. S., Lee, J. S., Matteson, E. L., Yi, E. S., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.09.002 · Cited by 130 · see citing works

IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases

Junjappa, R., Patil, P., Bhattarai, K. R., Kim, H., & Chae, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01289 · Cited by 114 · see citing works

Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis–Associated Interstitial Lung Disease

Mendoza, F. A., Piera‐Velazquez, S., Farber, J. L., Feghali‐Bostwick, C., & Jiménez, S. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39421 · Cited by 121 · see citing works

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

Monjarás-Ávila, C. U., Lorenzo‐Leal, A. C., Luque-Badillo, A. C., D’Costa, N. M., Chavez-Munoz, C. I., & Bach, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097946 · Cited by 106 · see citing works

Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis

López‐Cabrera, M. (2014) · Advances in Medicine · doi:10.1155/2014/473134 · Cited by 105 · see citing works

Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?

Jiménez, S. A., & Piera-Velázquez, S. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.012 · Cited by 104 · see citing works

Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury

Haak, A. J., Tsou, P.-S., Amin, M. A., Ruth, J. H., Campbell, P., Fox, D. A., Khanna, D., Larsen, S. D., & Neubig, R. R. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213520 · Cited by 103 · see citing works

Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH

Wasson, C. W., Abignano, G., Hermes, H. M., Malaab, M., Ross, R. L., Jiménez, S. A., Chang, H. Y., Feghali‐Bostwick, C. A., & Galdo, F. D. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216542 · Cited by 97 · see citing works

A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis

Shiwen, X., Stratton, R. J., Nikitorowicz-Buniak, J., Abdi, B. A., Ponticos, M., Denton, C. P., Abraham, D., Takahashi, A., Suki, B., Layne, M. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126015 · Cited by 95 · see citing works

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

del Río, C., Navarrete, C. M., Collado, J. A., Bellido, M. L., Gómez‐Cañas, M., Pazos, M. R., Fernández‐Ruíz, J., Pollastro, F., Appendino, G., Calzado, M. A., et al. (2016) · Scientific Reports · doi:10.1038/srep21703 · Cited by 93 · see citing works

Pathogenesis of systemic sclerosis—current concept and emerging treatments

Furue, M., Mitoma, C., Mitoma, H., Tsuji, G., Chiba, T., Nakahara, T., Uchi, H., & Kadono, T. (2017) · Immunologic Research · doi:10.1007/s12026-017-8926-y · Cited by 93 · see citing works

Pathogenesis of systemic sclerosis associated interstitial lung disease

Nihtyanova, S. I., & Denton, C. P. (2020) · Journal of Scleroderma and Related Disorders · doi:10.1177/2397198320903867 · Cited by 89 · see citing works

Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature

Ferri, C., Sebastiani, M., Monaco, A. L., Iudici, M., Giuggioli, D., Furini, F., Manfredi, A., Cuomo, G., Spinella, A., Colaci, M., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.029 · Cited by 88 · see citing works

Major lung complications of systemic sclerosis

Denton, C. P., Wells, A. U., & Coghlan, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0062-0 · Cited by 85 · see citing works

Advances in pathogenesis and treatment of systemic sclerosis

Denton, C. P. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-1-55 · Cited by 82 · see citing works

Treatment of Systemic Sclerosis–related Interstitial Lung Disease: A Review of Existing and Emerging Therapies

Volkmann, E. R., & Tashkin, D. P. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-426fr · Cited by 81 · see citing works

Fibroblast Memory in Development, Homeostasis and Disease

Kirk, T., Ahmed, A., & Rognoni, E. (2021) · Cells · doi:10.3390/cells10112840 · Cited by 78 · see citing works

T cell abnormalities in systemic sclerosis

Jin, W., Zheng, Y., & Zhu, P. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103185 · Cited by 78 · see citing works

Escape from X chromosome inactivation and female bias of autoimmune diseases

Mousavi, M. J., Mahmoudi, M., & Ghotloo, S. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00256-1 · Cited by 76 · see citing works

Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis

Chora, I., Guiducci, S., Manetti, M., Romano, E., Mazzotta, C., Bellando-Randone, S., Ibba‐Manneschi, L., Matucci‐Cerinic, M., & Soares, R. A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.001 · Cited by 75 · see citing works

Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.

Wermuth, P. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · PubMed · Cited by 68 · see citing works

Cardiovascular disease in systemic sclerosis

Nordin, A. (2014) · Figshare · Cited by 68 · see citing works

The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression

Kanno, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021796 · Cited by 67 · see citing works

The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis

Meng, M., Tan, J., Chen, W., Du, Q., Xie, B., Wang, N., Zhu, H., & Wang, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01861 · Cited by 66 · see citing works

Immune-Mediated Repair: A Matter of Plasticity

Laurent, P., Jolivel, V., Manicki, P., Chiu, L., Contin‐Bordes, C., Truchetet, M., & Pradeu, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00454 · Cited by 62 · see citing works

The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis

Kanno, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030619 · Cited by 62 · see citing works

Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis

Almadori, A., Griffin, M., Ryan, C. M., Hunt, D. F., Hansen, E., Kumar, R., Abraham, D., Denton, C. P., & Butler, P. E. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218068 · Cited by 60 · see citing works

Advances in pathogenesis and treatment of systemic sclerosis

Denton, C. P. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s58 · Cited by 60 · see citing works

Bioactive Plasma Mitochondrial DNA Is Associated With Disease Progression in Scleroderma‐Associated Interstitial Lung Disease

Ryu, C., Walia, A., Ortiz, V., Perry, C., Woo, S., Reeves, B. C., Sun, H., Winkler, J., Kanyo, J. E., Wang, W., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41418 · Cited by 58 · see citing works

Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90

Nazari, B., Rice, L. M., Stifano, G., Barron, A., Wang, Y. M., Korndorf, T., Lee, J. E., Bhawan, J., Lafyatis, R., & Browning, J. L. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.020 · Cited by 58 · see citing works

Recent Advances in Understanding the Pathogenesis of Scleroderma-Interstitial Lung Disease

Akter, T., Silver, R. M., & Bogatkevich, G. S. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-014-0411-1 · Cited by 57 · see citing works

The molecular pathogenesis of morphoea: from genetics to future treatment targets

Saracino, A., Denton, C. P., & Orteu, C. H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15001 · Cited by 57 · see citing works

BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs

Jin, J., Ou, Q., Wang, Z., Tian, H., Xu, J., Gao, F., Hu, S., Chen, J., Wang, J., Zhang, J., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02400-y · Cited by 57 · see citing works

Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features

Cipriani, P., Benedetto, P. D., Ruscitti, P., Campese, A. F., Liakouli, V., Carubbi, F., Pantano, I., Berardicurt, O., Screpanti, I., & Giacomelli, R. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0442-z · Cited by 56 · see citing works

Lung-kidney interactions and their role in chronic kidney disease-associated pulmonary diseases

Bollenbecker, S., Czaya, B. A., Gutiérrez, O. M., & Krick, S. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00152.2021 · Cited by 53 · see citing works

Tannic acid prevents macrophage-induced pro-fibrotic response in lung epithelial cells via suppressing TLR4-mediated macrophage polarization

Sivanantham, A., Pattarayan, D., Rajasekar, N., Kannan, A., Loganathan, L., Bethunaickan, R., Mahapatra, S. K., Rajaguru, P., Muthusamy, K., & Rajasekaran, S. (2019) · Inflammation Research · doi:10.1007/s00011-019-01282-4 · Cited by 53 · see citing works

A Method for Isolating and Culturing Skin Cells: Application to Endothelial Cells, Fibroblasts, Keratinocytes, and Melanocytes From Punch Biopsies in Systemic Sclerosis Skin

Henrot, P., Laurent, P., Levionnois, É., Leleu, D., Pain, C., Truchetet, M., & Cario, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566607 · Cited by 53 · see citing works

Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis

Bagnato, G. L., Irrera, N., Pizzino, G., Santoro, D., Roberts, W. N., Bagnato, G., Pallio, G., Vaccaro, M., Squadrito, F., Saitta, A., et al. (2018) · Clinical Science · doi:10.1042/cs20171426 · Cited by 51 · see citing works

Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis

Gilbane, A. J., Derrett‐Smith, E. C., Trinder, S. L., Good, R. B., Pearce, A. C., Denton, C. P., & Holmes, A. M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1464oc · Cited by 48 · see citing works

Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis

Ferri, C., Arcangeletti, M. C., Caselli, E., Zakrzewska, K., Maccari, C., Calderaro, A., D’Accolti, M., Soffritti, I., Arvia, R., Sighinolfi, G., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102727 · Cited by 48 · see citing works

Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis

Paul, S., Kaplan, M. H., Khanna, D., McCourt, P. M., Saha, A. K., Tsou, P., Anand, M., Radecki, A. A., Mourad, M., Sawalha, A. H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34775-8 · Cited by 47 · see citing works

Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis

García‐Martín, A., Garrido‐Rodríguez, M., Navarrete, C. M., Caprioglio, D., Palomares, B., DeMesa, J., Rollland, A., Appendino, G., & Muñóz, E. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.029 · Cited by 46 · see citing works

Management of Fibrosing Interstitial Lung Diseases

Maher, T. M., & Wuyts, W. A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00992-9 · Cited by 43 · see citing works

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis

Takata, M., Pachera, E., Frank‐Bertoncelj, M., Kozlova, A., Jüngel, A., Whitfield, M. L., Assassi, S., Calcagni, M., de Vries-Bouwstra, J. K., Huizinga, T. W. J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01100 · Cited by 41 · see citing works

Adipose Stromal Cell Expansion and Exhaustion: Mechanisms and Consequences

Eckel‐Mahan, K. L., Ribas‐Latre, A., & Kolonin, M. G. (2020) · Cells · doi:10.3390/cells9040863 · Cited by 41 · see citing works

Upregulation of the N -Formyl Peptide Receptors in Scleroderma Fibroblasts Fosters the Switch to Myofibroblasts

Rossi, F. W., Napolitano, F., Pesapane, A., Mascolo, M., Staibano, S., Matucci‐Cerinic, M., Guiducci, S., Ragno, P., Spigna, G. D., Postiglione, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402819 · Cited by 41 · see citing works

Strategy for treatment of fibrosis in systemic sclerosis: Present and future

Yanaba, K. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13026 · Cited by 40 · see citing works

Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase–like 4: New Evidence From Three‐Dimensional Skin‐like Tissues

Huang, M., Cai, G., Baugh, L. M., Liu, Z., Smith, A., Watson, M. C., Popovich, D., Zhang, T., Stawski, L., Trojanowska, M. E., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41163 · Cited by 40 · see citing works

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, I., Romano, E., Fioretto, B. S., & Manetti, M. (2020) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2019.19081 · Cited by 40 · see citing works

Correlation of retinal and choroidal microvascular impairment in systemic sclerosis

Rommel, F., Prangel, D., Prasuhn, M., Grisanti, S., & Ranjbar, M. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01649-5 · Cited by 40 · see citing works

Nanofibrillar Hydrogel Recapitulates Changes Occurring in the Fibrotic Extracellular Matrix

Prince, E., Chen, Z., Khuu, N., & Kumacheva, E. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.0c01714 · Cited by 40 · see citing works

Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression

Sng, M. K., Chan, J. S. K., Teo, Z. Q., Phua, T., Tan, E. H. P., Wee, J. W. K., Koh, N. J. N., Tan, C. K., Chen, J. P., Pal, M., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0014-5 · Cited by 39 · see citing works

VCE ‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB 2 receptor‐dependent pathways

del Río, C., Cantarero, I., Palomares, B., Gómez‐Cañas, M., Fernández‐Ruíz, J., Pavicic, C., García‐Martín, A., Bellido, M. L., Castro, R. O., Pérez‐Sánchez, C., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14450 · Cited by 38 · see citing works

The role of metabolism in the pathogenesis of systemic sclerosis

Zhu, H., Chen, W., Liu, D., & Luo, H. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.004 · Cited by 38 · see citing works

Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc)

Valentini, G. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.11.002 · Cited by 37 · see citing works

Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis

Chora, I., Romano, E., Manetti, M., Mazzotta, C., Costa, R., Machado, V., Cortez, A., Bruni, C., Lepri, G., Guiducci, S., et al. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.160791 · Cited by 37 · see citing works

M2 Macrophages Promote Collagen Expression and Synthesis in Laryngotracheal Stenosis Fibroblasts

Motz, K., Lina, I. A., Murphy, M. K., Drake, V. E., Davis, R. J., Tsai, H., Feeley, M., Yin, L. X., Ding, D., & Hillel, A. T. (2020) · The Laryngoscope · doi:10.1002/lary.28980 · Cited by 36 · see citing works

Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin

Mirizio, E., Liu, C., Yan, Q., Waltermire, J., Mandel, R., Schollaert, K. L., Konnikova, L., Wang, X., Chen, W., & Torok, K. S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.669116 · Cited by 35 · see citing works

Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients

Zanotti, S., Bragato, C., Zucchella, A., Maggi, L., Mantegazza, R., Morandi, L. O., & Mora, M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.015 · Cited by 34 · see citing works

SP0176 Role of Endothelial To Mesenchymal Transition in The Pathogenesis of The Vascular Alterations in Systemic Sclerosis

Jiménez, S. A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-eular.6222 · Cited by 34 · see citing works

Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis

Carvalheiro, T., Affandi, A. J., Malvar‐Fernández, B., Dullemond, I., Cossu, M., Ottria, A., Mertens, J. S., Giovannone, B., Bonte‐Mineur, F., Kok, M. R., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40915 · Cited by 33 · see citing works

Hydrogen inhalation attenuated bleomycin‐induced pulmonary fibrosis by inhibiting transforming growth factor‐β1 and relevant oxidative stress and epithelial‐to‐mesenchymal transition

Gao, L. Q., Jiang, D., Geng, J., Dong, R., & Dai, H. (2019) · Experimental Physiology · doi:10.1113/ep088028 · Cited by 33 · see citing works

Radiation-induced H3K9 methylation on E-cadherin promoter mediated by ROS/Snail axis : Role of G9a signaling during lung epithelial-mesenchymal transition

Nagaraja, S. S., Subramanian, U., & Nagarajan, D. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.105037 · Cited by 31 · see citing works

Role of NLRP3 inflammasome in systemic sclerosis

Lin, C., Jiang, Z., Cao, L., Zou, H., & Zhu, X. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02889-5 · Cited by 31 · see citing works

Treatment of rapidly progressive systemic sclerosis: current and futures perspectives

Mendoza, F. A., Mansoor, M., & Jiménez, S. A. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1114454 · Cited by 29 · see citing works

Detection of early endothelial damage in patients with Raynaud's phenomenon

Gualtierotti, R., Ingegnoli, F., Griffini, S., Grovetti, E., Borghi, M. O., Bucciarelli, P., Meroni, P. L., & Cugno, M. (2017) · Microvascular Research · doi:10.1016/j.mvr.2017.04.004 · Cited by 27 · see citing works

Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?

Fröhlich, J., & Vinciguerra, M. (2020) · GeroScience · doi:10.1007/s11357-020-00279-w · Cited by 27 · see citing works

Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis

Kim, Y., Nam, Y., Rim, Y. A., & Ju, J. H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02987-w · Cited by 26 · see citing works

Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology

Angelis, R. D., Ferri, C., Giuggioli, D., Bajocchi, G., Dagna, L., Bellando-Randone, S., Zanframundo, G., Foti, R., Cacciapaglia, F., Cuomo, G., et al. (2023) · RMD Open · doi:10.1136/rmdopen-2022-002890 · Cited by 26 · see citing works

Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma

Diddi, S., Bale, S., Pulivendala, G., & Godugu, C. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0527-4 · Cited by 26 · see citing works

Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity

Cutolo, M., Gotelli, E., Montagna, P., Tardito, S., Paolino, S., Pizzorni, C., Sulli, A., Smith, V. M., & Soldano, S. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02555-2 · Cited by 25 · see citing works

High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis

Miura, S., Iwamoto, H., Namba, M., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Ohshimo, S., et al. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001803 · Cited by 24 · see citing works

The Risk of Vocal Fold Atrophy after Serial Corticosteroid Injections of the Vocal Fold

Shi, L. L., Giraldez, L., & Johns, M. M. E. (2015) · Journal of Voice · doi:10.1016/j.jvoice.2015.10.004 · Cited by 24 · see citing works

Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy

Shibata, A., Kuno, M., Adachi, R., Sato, Y., Hattori, H., Matsuda, A., Okuzono, Y., Igaki, K., Tominari, Y., Takagi, T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186587 · Cited by 23 · see citing works

The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting

Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 23 · see citing works

Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications

Manetti, M., Romano, E., Rosa, I., Fioretto, B. S., Praino, E., Guiducci, S., Iannone, F., Ibba‐Manneschi, L., & Matucci‐Cerinic, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081256 · Cited by 22 · see citing works

The Pathophysiological Roles of Regulatory T Cells in the Early Phase of Systemic Sclerosis

Kobayashi, S., Nagafuchi, Y., Shoda, H., & Fujio, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900638 · Cited by 20 · see citing works

Protease Activated Receptor-1 Deficiency Diminishes Bleomycin-Induced Skin Fibrosis

Duitman, J., Ruela-de-Sousa, R. R., Shi, K., de Boer, O. J., Borensztajn, K., Florquin, S., Peppelenbosch, M. P., & Spek, C. A. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00027 · Cited by 19 · see citing works

Systemic sclerosis skin is a primed microenvironment for soft tissue calcification—a hypothesis

Burgess, K. A., Herrick, A. L., & Watson, R. E. B. (2021) · Rheumatology · doi:10.1093/rheumatology/keab156 · Cited by 19 · see citing works

Rho GTPase signaling in rheumatic diseases

Zeng, R., Zhuo, Z., Luo, Y., Sha, W., & Chen, H. H. (2021) · iScience · doi:10.1016/j.isci.2021.103620 · Cited by 19 · see citing works

Intact Calibers of Retinal Vessels in Patients with Systemic Sclerosis

Aissopou, E. K., Bournia, V.-K., Protogerou, A. D., Panopoulos, S., Papaioannou, T., Vlachoyiannopoulos, P. G., Matucci‐Cerinic, M., & Sfikakis, P. P. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141425 · Cited by 18 · see citing works

The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis

Kanno, Y., Shu, E., Kanoh, H., & Seishima, M. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.028 · Cited by 18 · see citing works

Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes

Ohta, S., Matsuura, M., Kawashima, Y., Cai, X., Taniguchi, M., Okochi, H., Asano, Y., Sato, S., & Ito, T. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.028 · Cited by 18 · see citing works

Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Sclerosis: 2 Distinct Entities?

Corallo, C., Santucci, A., Bernardini, G., Figura, N., Leoncini, R., Riolo, G., Montella, A., Chirico, C., Nuti, R., & Giordano, N. G. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.160736 · Cited by 17 · see citing works

The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting

Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 23 · see citing works

Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis

Korman, B. D. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.010 · Cited by 91 · see citing works

Unraveling SSc Pathophysiology; The Myofibroblast

van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153 · see citing works

The Mighty Fibroblast and Its Utility in Scleroderma Research

Garrett, S. M., Frost, D. B., & Feghali‐Bostwick, C. A. (2017) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000240 · Cited by 78 · see citing works

SP0047 Role of fibroblasts in scleroderma

Denton, C. P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-eular.1522 · Cited by 1 · see citing works